Online Formulary
Using the Formulary
Therapeutic Sections
1. Gastro-intestinal system
2. Cardiovascular system
3. Respiratory
4. Nervous system
5. Infection
6. Endocrine system
7. Genito-urinary system
8. Immune System
8. Malignant disease
9. Blood and blood-forming organs
9. Nutrition and metabolic disorders
10. Musculoskeletal system
11. Eye
12. Ear
12. Nose
12. Oropharynx
13. Skin
14. Vaccines
15. Anaesthesia
16. Emergency Treatment of Poisoning
Palliative Care
Wound management products
Stoma products
Continence products
Borderline substances
General recommendations and information
Shared Care
Using the Formulary
Therapeutic Sections
1. Gastro-intestinal system
2. Cardiovascular system
3. Respiratory
4. Nervous system
5. Infection
6. Endocrine system
6.1 Antidiuretic hormone disorders
6.2 Corticosteroid responsive conditions
6.3 Diabetes mellitus and hypoglycaemia
6.4 Disorders of bone metabolism
6.5 Dopamine responsive conditions
6.6 Gonadotrophin responsive conditions
6.7 Hypothalamic and anterior pituitary hormone related disorders
6.8 Sex hormone responsive conditions
6.9 Thyroid disorders
Local recommendations (Endocrine)
Local recommendations (Corticosteroids)
Local recommendations (Diabetes)
Local recommendations (Type 1 diabetes)
Local recommendations (Type 2 diabetes)
Local recommendations (Insulin)
Local Recommendations (SGLT2i)
Local recommendations (Diagnostic and monitoring devices for diabetes mellitus)
Local recommendations (Growth Hormone)
Local recommendations (Bone metabolism disorders)
Local recommendations (Sex responsive hormones)
Local recommendations (Thyroid)
7. Genito-urinary system
8. Immune System
8. Malignant disease
9. Blood and blood-forming organs
9. Nutrition and metabolic disorders
10. Musculoskeletal system
11. Eye
12. Ear
12. Nose
12. Oropharynx
13. Skin
14. Vaccines
15. Anaesthesia
16. Emergency Treatment of Poisoning
Palliative Care
Wound management products
Stoma products
Continence products
Borderline substances
General recommendations and information
Shared Care
Search
Feedback
Drug Status Key
On Formulary
Specialist Initiation
Shared Care
Hospital Only
Not Recommended
Preferences
First Line
Second Line
Third Line
No Preference
Local Recommendations (SGLT2i)
Recommendation
Approval date
Review date
Dapagliflozin in CKD guide
June 2022
June 2024
Kent and Medway SGLT2i Top Tips
October 2023
October 2025